Fludarabine
Top View
- Fludarabine, High-Dose Cytarabine and Idarubicin-Based
- Acronyms for Oncology Regimens
- All-Trans Retinoic Acid and Arsenic Trioxide Resistance of Acute Promyelocytic Leukemia with the Variant STAT5B-RARA Fusion Gene
- LYFCR Protocol
- Fludarabine Plus Cyclophosphamide Combination: a New Standard for First-Line Therapy in Chronic Lymphocytic Leukaemia
- Chemotherapy Drugs
- Modifying Chemotherapy for the Older Patient
- Subcutaneous Administration of Anticancer Agents
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Prognostic Impact of Combined Fludarabine, Treosulfan and Mitoxantrone Resistance Profile in Childhood Acute Myeloid Leukemia
- The Inhibitor of Histone Deacetylases Sodium Butyrate Enhances the Cytotoxicity of Mitomycin C
- Fludarabine As First Line Therapy for Chronic Lymphocytic Leukaemia
- Emetogenic Potential of Antineoplastic Agents
- (PDF) Download
- NCCN Guidelines for Acute Myeloid Leukemia from the 1.2014 Version Include
- Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway Via
- Adult Antiemetic Management of Chemotherapy-Induced Nausea
- The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye